Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1200-2017Class II

VIDAS 3 software v. 1.1.4

bioMerieux, Inc. / initiated 2017-01-11 / Terminated / root cause: software

BioMerieux SA began a recall of VIDAS 3 software v. 1.1.4 on . FDA classified it as Class II and gives the reason as "During development of the VIDAS 3 software version 1.2, some anomalies have been identified and observed to be already present in the current software version VIDAS 3 version 1.1.4. available in the field". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1200-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
bioMerieux, Inc.
Product
VIDAS 3 software v. 1.1.4
Product code
LFZ Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus
Reason for recall
During development of the VIDAS 3 software version 1.2, some anomalies have been identified and observed to be already present in the current software version VIDAS 3 version 1.1.4. available in the field.
Root cause tag
software
FDA root cause
Software in the Use Environment
Action
Consignees were notified via letter on January 11th, 2017.
Quantity in commerce
1161 units
Distribution
U.S.
Product codes and lots
REF: #412590, Lot: Software version 1.1.4

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1200-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1200-2017Class IITerminatedVoluntary: Firm initiated